Anne Kim
Lawyers
Filters
Abbott Laboratories $20 billion notes offering
We advised the joint book-running managers on the offering
AbbVie $8 billion senior notes offering
We advised the representatives of the underwriters on the offering
RXO $400 million senior notes offering
We advised the representative of the initial purchasers on the offering
Eikon Therapeutics $381 million IPO
We advised the representatives of the several underwriters on the IPO
Aktis Oncology $318 million IPO
This is the first biotech IPO of 2026
DXC Technology €650 million senior notes offering
We advised the initial purchasers on the investment-grade debt offering
Esperion Therapeutics follow-on offering
The shares are listed on Nasdaq
Neptune $368 million IPO
The shares are listed on the New York Stock Exchange
Somnigroup International $953 million secondary offering
The shares are listed on the New York Stock Exchange
General Motors $2 billion senior notes offering
The investment-grade notes offering consists of three tranches